John B. Landis Eye Point Pharmaceuticals, Inc. (EYPT) insider trading activity

EYPT Quotes by TradingView

John B. Landis is of EyePoint Pharmaceuticals, Inc.. Currently has a direct ownership of 21,400 shares of EYPT, which is worth approximately $154,080. The most recent transaction as insider was on Jan 05, 2025, when has been sold 10,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.4K
87.72% 3M change
87.72% 12M change
Total Value Held $154,080

John B. Landis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 05 2025
BUY
Exercise of conversion of derivative security
-
10,000 Added 31.85%
21,400 Common Stock
Feb 09 2023
BUY
Exercise of conversion of derivative security
-
3,000 Added 20.83%
11,400 Common Stock
Feb 09 2022
BUY
Exercise of conversion of derivative security
-
2,500 Added 22.94%
8,400 Common Stock
Feb 28 2021
BUY
Exercise of conversion of derivative security
-
1,900 Added 24.36%
5,900 Common Stock
JBL

John B. Landis

Watertown, MA

Track Institutional and Insider Activities on EYPT

Follow EyePoint Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EYPT shares.

Notify only if

Insider Trading

Get notified when an Eye Point Pharmaceuticals, Inc. insider buys or sells EYPT shares.

Notify only if

News

Receive news related to EyePoint Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EYPT